The next #CHEST2021 session for tweet-ucation is "COVID-19: Other Considerations in Management"! 1/
Derlis Fleitas Sosa talks on "Significant dyspnea in post-acute COVID-19 is associated with abnormal pulmonary vasculature on CT during the acute phase." #CHEST2021 2/
Their hypothesis #CHEST2021 3/
Methods #CHEST2021 4/
They used functional respiratory imaging. #CHEST2021 5/
Results - Similar across both groups at baseline. #CHEST2021 6/
Follow-up data. They found changed size of blood vessels that were different. #CHEST2021 7/
Conclusions #CHEST2021 8/
Clinical implications #CHEST2021 9/
Tamana Ahmadi talks about "Standard vs high-intensity prophylactic anticoagulation in COVID-19: A US, Californian retrospective study." #CHEST2021 10/
Background data - Thrombotic microangiopathy has been well-described in COVID-19 patients. #CHEST2021 11/
The questions they asked #CHEST2021 12/
Population #CHEST2021 13/
Methods #CHEST2021 14/
Analysis #CHEST2021 15/
Baseline characteristics #CHEST2021 16/
28 day mortality #CHEST2021 17/
Odds ratio for mortality #CHEST2021 18/
Clinical implications #CHEST2021 19/
Hamid Yaqoob will be speaking on "Predictors and outcomes of bacterial and fungal superinfections in critically ill patients witH COVID-19". #CHEST2021 20/
Introduction #CHEST2021 21/
Aims #CHEST2021 22/
Methods #CHEST2021 23/
Outcome measures of interest #CHEST2021 24/
Results #CHEST2021 25/
Conclusions #CHEST2021 26/
Abasin Amanzai will speak on "Did we need those antibiotics? Outcomes of patients with COVID-19 treated for bacterial superinfection of the lungs". #CHEST2021 27/
Background #CHEST2021 28/
Methods #CHEST2021 29/
Results #CHEST2021 30/
Conclusions and Implications #CHEST2021 31/
Rainy Zhang will be speaking on "Utility of D-dimer cut-off point with VTE in critically ill patients with COVID-19". #CHEST2021 32/
Background #CHEST2021 33/
Methods #CHEST2021 34/
Results #CHEST2021 35/
Conclusion #CHEST2021 36/
Christopher Millet will speak on "The Long Haul: A follow-up study of patients diagnosed with COVID-19 one year ago at an urban medical center in NJ" #CHEST2021 37/
Introduction #CHEST2021 38/
Methods #CHEST2021 39/
Outpatients had more persistent symptoms. #CHEST2021 40/
Conclusions #CHEST2021 41/41
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.